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Summary
Anorexia nervosa (AN) is characterized by severe dietary restriction or other weight loss behaviors 
and exhibits the highest mortality rate of any psychiatric disorder. Therapeutic renourishment in 
AN is founded primarily on clinical opinion and guidelines, with a weak evidence base. Genetic 
factors do not fully account for the etiology of AN, and non-genetic factors that contribute to the 
onset and persistence of this disease warrant investigation. Compelling evidence that the intestinal 
microbiota regulates adiposity and metabolism, and more recently, anxiety behavior, provides a 
strong rationale for exploring the role of this complex microbial community in the onset, 
maintenance of, and recovery from AN. This review explores the relationship between the 
intestinal microbiota and AN and a potential role for this enteric microbial community as a therapy 
for this severe illness.
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Introduction
Anorexia nervosa (AN) is a highly morbid disease that affects approximately 0.9% of 
women and 0.3% of men in the United States.[1] The disorder is characterized by severe 
dietary restriction or other weight-loss behaviors, such as purging or excessive physical 
activity, an intense fear of weight gain, and a disturbed body image.[2] In addition to the 
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obvious sequelae of poor energy intake, the disorder has several psychological 
consequences, including social isolation, feelings of worthlessness, and resistance to 
treatment.[3] For this reason and others, outcomes are generally poor, and AN exhibits the 
highest mortality rate of any psychiatric disorder.[4,5] Despite significant morbidity and 
mortality,[1,4-6] the evidence base for the treatment of AN is meager.[7,8]
Approaches to weight restoration are rarely evidence-based but rather based on clinical 
opinion and experience, and are reported to be uncomfortable and distressing to patients.[8] 
Additionally, these approaches often fail to restore a healthy body fat distribution. 
Redistribution after refeeding is not uniform, with disproportionate central adipose tissue 
deposition. This unequal distribution is marked by an elevated waist-to-hip ratio, which 
indicates central obesity, as well as increased total trunk fat and visceral adipose tissue.[9] 
Poor treatment outcome is, in part, due to the fact that the biology of AN and the physical 
adaptations that occur during weight restoration are inadequately understood, rendering it 
difficult to design effective treatment interventions that target the core features of the illness.
Genetic epidemiological investigations indicate that AN has a strong genetic etiology.
[10,11] Indeed, a significant familial association has been reported for AN,[12,13] and twin 
studies estimate heritability at over 60%.[10,11,14,15] Genes do not act alone: 
environmental factors—either directly or via gene-environment co-action—also influence 
risk. The intestinal microbiota, which describes the community of microorganisms living 
within the intestinal tract, has been shown to have a crucial role in metabolic function, 
accumulation and storage of fat, and behavior (e.g., anxiety and stress).[16-21] This 
highlights the intestinal microbiota as a compelling topic of exploration, as our 
understanding of the manner in which the intestinal microbiota affects the development and 
maintenance of AN may allow us to effectively improve our treatment of AN. The following 
sections review the current evidence for the role of the intestinal microbiota in regulating 
several elements of AN—the development of adiposity and behavior control—and explore 
the direct role of the intestinal microbiota in AN.
The Intestinal Microbiota and Adiposity
The intestinal microbiota plays an important role in weight regulation in both humans and 
animals, and consistent evidence implicates this enteric microbial community in obesity—
though the extent of that contribution is controversial. Early work by Ley et al. reported that 
differences in weight were associated with differential composition of the intestinal 
microbiota, with the enteric microbiota in genetically obese mice (ob/ob) demonstrating a 
50% reduction in abundance of the Bacteroidetes phylum and a parallel increase in 
Firmicutes phylum compared with wild-type siblings fed the same fat-heavy diet.[22] 
Similarly, studies in humans revealed that obese individuals have relatively fewer 
Bacteroidetes and more Firmicutes than lean controls,[23] but a one-year low-calorie diet 
(either low-fat or low-carbohydrate) can raise the relative level of Bacteroidetes and lower 
the relative level of Firmicutes in obese individuals. Subsequent research both 
confirmed[24-26] and refuted[18,27-29] the association between obesity and increased 
Firmicutes/decreased Bacteroidetes. Taken together, these data suggest that weight affects 
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the composition of the intestinal microbiota, and that diet alone may alter this composition 
as well.
Recent studies changed focus from observational to experimental, introducing 
mouse:mouse, human:mouse, and human:human fecal transplants. A key study showed that 
the intestinal microbiotas of obese mice are more effective at extracting energy from food 
than those of lean mice, and that this trait can be passed to germ-free (GF) mice via 
microbial transplantation, causing increased adiposity.[30] Transferring fecal samples from 
obese adult females into GF mice also reveals that increased body fat, fat mass, and obesity-
associated metabolic phenotypes can be transferred via the intestinal microbiota.[31] 
Furthermore, studies suggest that the presence of a “normal” microbiota can reverse or 
negate the direct effects of possessing an “obese” microbiota. Wild-type mice harboring an 
obese mouse's microbiota (Ob) cohoused with wild-type mice harboring microbiota from the 
Ob's lean co-twin (Ln) prevented the development of increased body mass and obesity-
associated metabolic phenotypes in Ob cage-mates.[31] Fecal transplants from healthy 
human male donors (BMI <23) to obese males with metabolic syndrome led to improved 
insulin sensitivity after six weeks compared with individuals who received transplants 
created from their own stool samples.[32]
The Intestinal Microbiota and Behavior
Mood and behavior significantly impact maintenance of a healthy weight.[33] For example, 
dysregulated affective states (e.g., increased stress and anxiety) are prevalent in patients 
prior to bariatric surgery, and negative affective states (e.g., anxiety) can adversely influence 
the maintenance of weight loss.[34] While the relationship between mood and weight is still 
unclear, a growing body of evidence indicates a strong connection between the brain and the 
intestinal microbiota.[35,36] Early findings in animal models suggest a direct association 
between the intestinal microbiota and stress-like and/or depressive behaviors,[36] and the 
collective body of evidence suggests bidirectional communication between the intestinal 
microbiota and brain function in times of both homeostasis and disease.[37] This 
communication appears to occur primarily through complex interactions along the 
hypothalamic-pituitary-adrenal (HPA) axis and structures in the central nervous system 
(CNS) that can affect cognition, mood, and emotion. For example, Sudo and colleagues[20] 
investigated the potential role of the intestinal microbiota in altering HPA axis function, 
which is purported to be involved in depression. These investigators found that inducing 
stress in GF mice caused an exaggerated hormonal response of the HPA axis compared with 
conventionally raised mice. Notably, stress is also implicated in the pathogenesis of both 
depression and compositional changes in the intestinal microbiota, which may confound 
these findings. Nonetheless, the exaggerated hormonal response was reversed by 
introduction of Bifidobacterium infantis, a member of the normal intestinal microbiota, to 
GF mice. Similarly, a series of studies by Lyte et al.[38] demonstrated that oral 
administration of Campylobacter jejuni, a bacterium commonly associated with 
gastroenteritis, caused behaviors suggestive of anxiety in mice, as measured by exploratory 
behavior on an elevated plus-maze. A more recent study found that diversifying the 
intestinal microbiota through alteration of the diet resulted in improvements in working 
memory and reduced anxiety-like behavior in mice.[21] As AN patients exhibit elevated 
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levels of anxiety,[39] complex enteric microbial communities may potentially influence this 
behavior in patients with AN (Figure 1). Although further studies are needed to elucidate the 
complex interactions between the intestinal microbiota and mood/behavior, the extant 
literature suggests this field is particularly rich for exploration into the causes and potential 
treatment of mood disorders.
The Intestinal Microbiota and Anorexia Nervosa
Although the composition of the intestinal microbiota differs between obese and lean 
individuals, and obese (versus lean) individuals may extract more energy from a given diet, 
very little is known about the intestinal microbiota in individuals with eating disorders—and 
the limited research in this area has focused on AN. In a small cohort, one study 
characterized bacterial composition in AN inpatients (n=16) versus healthy controls (n=12), 
and found that AN patients had significantly lower alpha (within-sample) diversity than 
healthy controls, as well as differences between groups in taxa abundance.[19] To more 
specifically characterize the bacterial species in AN, another study used traditional microbial 
culturing techniques of a single stool sample from a patient with acute AN and identified 11 
completely new species in the phyla Firmicutes (n=7), Bacteroidetes (n=2), and 
Actinobacteria (n=2).[40] This suggests distinct characteristics of the intestinal microbiota in 
AN, an illness that truly represents a unique nutrient-impoverished state. Further research is 
needed to investigate whether these new species are specifically associated with AN.
In addition, a cross-sectional study analyzing the intestinal microbiota of nine patients with 
AN found increased levels of the archaeon Methanobrevibacter smithii, which plays an 
important role in efficiency of microbial fermentation and associated energy yield from one's 
diet. This difference could reflect an adaptive response in those individuals with AN to a 
prolonged very low-calorie diet.[24] Because this study analyzed a limited number of 
microbial groups, further studies are needed to more comprehensively characterize the 
composition of the intestinal microbiota in individuals with AN, and any changes in this 
composition as they undergo therapeutic re-nourishment. A summary of these findings is 
provided in Table 1.
Early mechanistic research in animal models also suggests that the intestinal microbiota 
plays a role in satiety via interaction with peptide signaling,[41] which may be sex-specific. 
These early, promising findings suggest that research into the role of the intestinal 
microbiota in the development, maintenance, and recovery from eating disorders will reveal 
exciting advances in our understanding of the role of the intestinal microbiota in the 
development and treatment of AN. Likewise, next generation research on this topic will 
expand beyond studies of patients with AN to include other disorders, such as bulimia 
nervosa, binge-eating disorder, and avoidant/restrictive food intake disorder.
Five Year View
Studies involving transplantation of intact, uncultured microbiotas from healthy humans to 
individuals with Clostridium difficile-induced colitis or patients with metabolic syndrome 
have yielded proof-of-principle that the intestinal microbiota represents a valid therapeutic 
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target for treating or preventing disease.[32,42,43] These findings provide a basis for the use 
of fecal microbiota transplantation beyond the treatment of C. difficile and metabolic 
syndrome. Supporting this concept, manipulation of the intestinal microbiota via 
administration of probiotics has also been shown to be effective in several disease states, 
including acute childhood diarrhea.[44] Likewise, a probiotic originally isolated from the 
intestinal microbiota of a healthy individual (Lactobacillus rhamnosus JB-1) reduced 
anxiety- and stress-related behavior in mice via modulation of the expression of gamma-
aminobutyric acid (GABA) in the brain.[45] These biological and behavioral effects were 
not seen in vagotomized mice, illustrating the critical role of microbe-gut-brain 
communication.[45] Given the impact that enteric microbial communities appear to have on 
traits that are commonly seen in individuals with AN and that a dysbiotic intestinal 
microbiota has been reported in this patient population, a potential to develop safe and 
effective therapies using or targeting gut microbes exists. However, it remains to be 
determined which specific bacterial strains or the metabolites they produce are responsible 
for dysregulated weight, adiposity, and behavior in AN patients. Additionally, one of the 
most important questions regarding the relationship between alterations in the intestinal 
microbiota and disease is whether a dysbiotic enteric microbial community is a cause or 
consequence of health status. Additional studies are required to delineate whether changes in 
the composition of the intestinal microbiota are a cause or consequence of AN. Future 
studies will likely identify dysregulated host-microbe interactions that may ultimately be 
targeted leading to novel therapies for this serious illness.
Expert Commentary
The composition of the intestinal microbiota has been a subject of study for decades, and 
many factors are known to affect the survival of microbes in the human gut. However, the 
body of research examining the relationship between intestinal microbiota and eating 
disorders is in its infancy. Enteric microbial communities can directly affect adiposity and 
weight regulation, although the degree and mechanism of this influence is still under 
investigation. Adiposity and weight are not the only intestinal microbiota-influenced traits 
that are relevant to eating disorders. Mood and behavior are integral features of eating 
disorders and evidence is rapidly accumulating documenting the impact of this complex 
microbial community on anxiety, depression, and other psychological symptoms.
[16,36,45-49]
Extending research on the intestinal microbiota to AN and other eating disorders is logical 
and inevitable. AN is a debilitating and potentially lethal disorder characterized by severe 
and often prolonged dietary restriction that drastically alters the intestinal environment. 
Findings in this area could have immediate relevance to the prognosis, treatment, and 
process of recovery from AN. Specifically, based on the profile of the intestinal microbiota 
(presence or absence of specific enteric microbes or composition and/or diversity) in AN 
patients, it may become possible to identify which individuals will experience difficulties 
with weight restoration, and who will succeed in maintaining therapeutically restored weight 
versus relapse. Ultimately, we may identify specific bacterial taxa whose promotion or 
elimination would improve the efficiency of therapeutic weight restoration, as well as the 
psychological and physical treatment experience of patients.
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Key Issues
• Anorexia nervosa is a serious illness with the highest mortality rate of any 
psychiatric disorder; the evidence base for treatment, especially in adults, is 
scant.
• Renourishment is a critical first step in treatment but can cause discomfort and 
result in central distribution of body fat.
• As the intestinal microbiota affects metabolism, fat accumulation and storage, 
and behavior, it is worthy of investigation in anorexia nervosa.
• The intestinal tract of patients with AN is a nutrient-poor environment and may 
select for microorganisms that can survive under those conditions.
• Two hypotheses exist regarding the differences between the intestinal 
microbiotas of lean (or anorexic) and obese humans: (i) differing microorganism 
compositions may harvest energy from food with different efficiencies; or (ii) 
certain microorganisms may produce metabolites that differentially impact 
feelings of satiation.
• Research into the relationship between eating disorders such as AN and the 
intestinal microbiota continues. More knowledge about the roles that specific 
microorganisms play in the “microbe-gut-brain axis” and the mechanisms by 
which these interactions occur could lead to innovative therapies for AN.
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Figure 1. 
Potential relationship between the intestinal microbiota and behavior in patients with 
Anorexia Nervosa. Restricting calorie intake can have a profound impact on enteric 
microbes resulting in decreased microbial richness and a bloom of bacteria that can flourish 
in a nutrient depleted environment. This altered composition in the intestinal microbiota 
could possibly impact the behavior of a patient with Anorexia Nervosa, perpetuating 
restriction of food intake.
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Table 1
Studies that have characterized the enteric microbial communities in patients with AN
Author Journal Publication Year Population Results
Kleiman et al. 
[19]
Psychosomatic Medicine 2015 AN inpatients (n=16) 
vs. healthy controls 
(n=12)
Patients with AN demonstrate significant 
changes between hospital admission and 
discharge in taxa abundance and beta 
(between-sample) diversity; patients with 
AN demonstrate lower alpha (within-sample) 
diversity than healthy controls. AN and 
healthy controls demonstrate differences in 
taxa abundance
Pfleiderer et 
al. [40]
European Journal of 
Clinical Microbiology & 
Infectious Diseases
2013 Single AN patient Identified 133 bacterial species, including 19 
species never before isolated from the human 
gut, and sequenced 11 of these new species 
in the phyla Firmicutes, Bacteroides & 
Actinobacteria
Armougom et 
al. [24]
PLoS One 2009 Obese patients (n=20), 
AN patients (n=9) & 
healthy controls 
(n=20)
AN patients demonstrated reduced levels of 
Lactobacillus species compared with obese 
individuals or healthy controls, and increased 
levels of the archaeon Methanobrevibacter 
smithii
Expert Rev Gastroenterol Hepatol. Author manuscript; available in PMC 2016 May 09.
